Documentos relacionados

1. High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis.
2. Stevens-Johnson syndrome in children.
3. Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus.
4. Stevens-Johnson syndrome and toxic epidermal necrolysis from pathologist's point of view.
5. Toxic epidermal necrolysis-like presentation of toxic erythema of chemotherapy.
6. Severe reactive infectious mucocutaneous eruption mimicking drug-induced epidermal necrolysis triggered by norovirus.
7. Fast, bedside diagnosis of toxic epidermal necrolysis using ex vivo confocal laser scanning microscopy: A retrospective study.
8. APOA4 as a novel predictor of prognosis in Stevens-Johnson syndrome/toxic epidermal necrolysis: A proteomics analysis from two prospective cohorts.
9. Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).
10. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.